SXI Form 4: 639-share restricted stock grant; post-holdings 6,639
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Standex International (SXI) reported an insider equity award. A director received a grant of 639 shares of common stock on 10/21/2025, coded as an acquisition under the company’s 2018 Omnibus Incentive Plan. The grant price was $0, and the restricted stock is scheduled to vest three years after the grant date.
Following this grant, the reporting person beneficially owns 6,639 shares, held directly. This filing reflects routine director compensation in equity rather than an open‑market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
NEMETH ANDY L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 639 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 6,639 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Standex (SXI) disclose in this Form 4?
A director received a grant of 639 shares of common stock on 10/21/2025 under the 2018 Omnibus Incentive Plan.
What is the vesting schedule for the SXI restricted stock grant?
The restricted stock vests three years after the date of grant.
What was the transaction price for the SXI equity award?
The reported price for the restricted stock grant was $0.
What transaction code appears on the SXI Form 4?
The filing lists code A (1), indicating an acquisition, with the note explaining a restricted stock grant.
Which plan governed the SXI restricted stock grant?
The shares were granted under the company’s 2018 Omnibus Incentive Plan.